15.48MMarket Cap-7.01P/E (TTM)
1.840High1.600Low14.74KVolume1.756Open1.820Pre Close24.98KTurnover0.48%Turnover RatioLossP/E (Static)9.44MShares5.50052wk High1.64P/B5.00MFloat Cap1.42052wk Low--Dividend TTM3.05MShs Float5.500Historical High--Div YieldTTM13.18%Amplitude1.420Historical Low1.694Avg Price1Lot Size
Gelteq Stock Forum
Gelteq Launches SportsGel Brand and Signs Distribution Agreement with E-Commerce Solutions Company in Asia-Pacific Region, WPIC
Tuesday, 4th February at 8:00 am
NEW YORK, Feb. 04, 2025 (GLOBE NEWSWIRE) -- Gelteq Limited(NASDAQ: GELS) ("Gelteq" or the "Company"), a global biotechnology company that specializes in the formulation, development, and manufacturing of ingestible gel technology, announces the launch of its SportsGel brand. "SportsGel has been established to elimin...
Gelteq Launches Sportsgel Brand and Signs Distribution Agreement With E-Commerce Solutions Company in Asia-Pacific Region, Wpic
📊⚡️📊
Gelteq Receives FDA Approval of its Suitability Petition for New Animal Drug
Tuesday, 17th December at 8:30 am
NEW YORK, Dec. 17, 2024 (GLOBE NEWSWIRE) -- Gelteq Limited (NASDAQ: GELS) ("Gelteq" or the "Company"), a clinical and biotechnology company focused on developing and commercializing white label gel-based delivery solutions for prescription drugs, nutraceuticals, pet care, sports, and other products, announces today that the U.S. Food and Drug Administration ("FDA")...
Gelteq Receives FDA Approval of Its Suitability Petition for New Animal Drug
No comment yet